Securing the future of nutritional sciences through integrative graduate education.
J Nutr.
2002 Apr;132(4):779-84. doi: 10.1093/jn/132.4.779. PubMed PMID:
11925477.
Alterations in enterocyte proliferation and apoptosis accompany TPN-induced mucosal hypoplasia and IGF-I-induced hyperplasia in rats.
J Nutr.
2002 Jul;132(7):2010-4. doi: 10.1093/jn/132.7.2010. PubMed PMID:
12097684.
Training down-regulates fatty acid synthase and body fat in obese Zucker rats.
Med Sci Sports Exerc.
2002 Jul;34(7):1106-14. doi: 10.1097/00005768-200207000-00009. PubMed PMID:
12131249.
IGF-I treatment facilitates transition from parenteral to enteral nutrition in rats with short bowel syndrome.
Am J Physiol Regul Integr Comp Physiol.
2003 Feb;284(2):R363-71. doi: 10.1152/ajpregu.00247.2002. Epub 2002 Sep 27. PubMed PMID:
12388469.
Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection.
Am J Physiol Gastrointest Liver Physiol.
2003 Apr;284(4):G670-82. doi: 10.1152/ajpgi.00293.2002. Epub 2002 Dec 27. PubMed PMID:
12505881.
Liposome-encapsulated oxymorphone hydrochloride provides prolonged relief of postsurgical visceral pain in rats.
Comp Med.
2003 Jun;53(3):270-9. PubMed PMID:
12868572.
Introducing a problem-based unit into a lifespan nutrition class using a randomized design produces equivocal outcomes.
J Am Diet Assoc.
2003 Aug;103(8):1020-5. doi: 10.1016/s0002-8223(03)00478-4. PubMed PMID:
12891152.
IGF-I augments resection-induced mucosal hyperplasia by altering enterocyte kinetics.
Am J Physiol Regul Integr Comp Physiol.
2003 Oct;285(4):R800-8. doi: 10.1152/ajpregu.00014.2003. Epub 2003 May 22. PubMed PMID:
12763742.
Intestinal adaptation occurs independently of parenteral long-chain triacylglycerol and with no change in intestinal eicosanoids after mid-small bowel resection in rats.
J Nutr.
2004 Jan;134(1):112-9. doi: 10.1093/jn/134.1.112. PubMed PMID:
14704302.
Postreceptor resistance to exogenous growth hormone exists in the jejunal mucosa of parenterally fed rats.
J Nutr.
2004 Mar;134(3):530-7. doi: 10.1093/jn/134.3.530. PubMed PMID:
14988442.
Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation.
Gastroenterology.
2004 Aug;127(2):570-81. doi: 10.1053/j.gastro.2004.05.016. PubMed PMID:
15300589.
Hypoenergetic high-carbohydrate or high-fat parenteral nutrition induces a similar metabolic response with differential effects on hepatic IGF-I mRNA in dexamethasone-treated rats.
J Nutr.
2005 Mar;135(3):479-85. doi: 10.1093/jn/135.3.479. PubMed PMID:
15735081.
Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells.
Am J Physiol Gastrointest Liver Physiol.
2005 Aug;289(2):G342-50. doi: 10.1152/ajpgi.00413.2004. Epub 2005 Apr 14. PubMed PMID:
15831713.
Insulin-like growth factor-I (IGF-I) attenuates jejunal atrophy in association with increased expression of IGF-I binding protein-5 in parenterally fed mice.
J Nutr.
2005 Nov;135(11):2553-9. doi: 10.1093/jn/135.11.2553. PubMed PMID:
16251610.
Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome.
Am J Clin Nutr.
2006 Nov;84(5):1142-50. doi: 10.1093/ajcn/84.5.1142. PubMed PMID:
17093168.
Vagal afferents are essential for maximal resection-induced intestinal adaptive growth in orally fed rats.
Am J Physiol Regul Integr Comp Physiol.
2006 Nov;291(5):R1256-64. doi: 10.1152/ajpregu.00247.2006. PubMed PMID:
17028287.
Loss of exocrine pancreatic stimulation during parenteral feeding suppresses digestive enzyme expression and induces Hsp70 expression.
Am J Physiol Gastrointest Liver Physiol.
2007 Mar;292(3):G857-66. doi: 10.1152/ajpgi.00467.2006. Epub 2006 Nov 30. PubMed PMID:
17138970.
Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat.
Endocrinology.
2007 May;148(5):1954-62. doi: 10.1210/en.2006-1232. Epub 2007 Jan 18. PubMed PMID:
17234710.
Intestinotrophic effects of exogenous IGF-I are not diminished in IGF binding protein-5 knockout mice.
Am J Physiol Regul Integr Comp Physiol.
2007 Jun;292(6):R2144-50. doi: 10.1152/ajpregu.00903.2006. Epub 2007 Mar 1. PubMed PMID:
17332154.
Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKU.
Mol Genet Metab.
2007 Sep-Oct;92(1-2):176-8. doi: 10.1016/j.ymgme.2007.06.004. Epub 2007 Jul 23. PubMed PMID:
17644019; PubMed Central PMCID:
PMC2032016.
Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.
J Nutr.
2008 Feb;138(2):316-22. doi: 10.1093/jn/138.2.316. PubMed PMID:
18203898.
Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats.
Am J Physiol Regul Integr Comp Physiol.
2008 Apr;294(4):R1175-84. doi: 10.1152/ajpregu.00238.2007. Epub 2008 Feb 6. PubMed PMID:
18256135.
Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.
JPEN J Parenter Enteral Nutr.
2008 May-Jun;32(3):254-65. doi: 10.1177/0148607108316198. PubMed PMID:
18443137; PubMed Central PMCID:
PMC3631545.
Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism.
Curr Opin Lipidol.
2008 Jun;19(3):248-56. doi: 10.1097/MOL.0b013e3282f9b54d. Review. PubMed PMID:
18460915; PubMed Central PMCID:
PMC4201499.
Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.
Am J Physiol Regul Integr Comp Physiol.
2008 Dec;295(6):R1794-802. doi: 10.1152/ajpregu.90616.2008. Epub 2008 Oct 1. PubMed PMID:
18832087; PubMed Central PMCID:
PMC2685304.
Assessing validity and reliability of resting metabolic rate in six gas analysis systems.
J Am Diet Assoc.
2009 Jan;109(1):128-32. doi: 10.1016/j.jada.2008.10.004. PubMed PMID:
19103333; PubMed Central PMCID:
PMC2650235.
Nutritional management of PKU with glycomacropeptide from cheese whey.
J Inherit Metab Dis.
2009 Feb;32(1):32-9. doi: 10.1007/s10545-008-0952-4. Epub 2008 Oct 29. Review. PubMed PMID:
18956251; PubMed Central PMCID:
PMC3633220.
Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids.
Am J Clin Nutr.
2009 Apr;89(4):1068-77. doi: 10.3945/ajcn.2008.27280. Epub 2009 Feb 25. PubMed PMID:
19244369; PubMed Central PMCID:
PMC2667457.
Purification and use of glycomacropeptide for nutritional management of phenylketonuria.
J Food Sci.
2009 May-Jul;74(4):E199-206. doi: 10.1111/j.1750-3841.2009.01134.x. PubMed PMID:
19490325; PubMed Central PMCID:
PMC3632067.
Senescent swallowing: impact, strategies, and interventions.
Nutr Clin Pract.
2009 Jun-Jul;24(3):395-413. doi: 10.1177/0884533609332005. Review. PubMed PMID:
19483069; PubMed Central PMCID:
PMC2832792.
Colonic GLP-2 is not sufficient to promote jejunal adaptation in a PN-dependent rat model of human short bowel syndrome.
JPEN J Parenter Enteral Nutr.
2009 Nov-Dec;33(6):629-38; discussion 638-9. doi: 10.1177/0148607109336597. Epub 2009 Jul 30. PubMed PMID:
19644131; PubMed Central PMCID:
PMC3631543.
Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed rats.
Am J Physiol Regul Integr Comp Physiol.
2009 Nov;297(5):R1554-62. doi: 10.1152/ajpregu.00423.2009. Epub 2009 Sep 23. PubMed PMID:
19776251; PubMed Central PMCID:
PMC2777771.
Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes.
Mol Genet Metab.
2009 Dec;98(4):331-7. doi: 10.1016/j.ymgme.2009.07.016. Epub 2009 Aug 8. PubMed PMID:
19747868; PubMed Central PMCID:
PMC2783926.
Total parenteral nutrition attenuates cerulein-induced pancreatitis in rats.
Pancreas.
2010 Apr;39(3):377-84. doi: 10.1097/MPA.0b013e3181bb908e. PubMed PMID:
19904225; PubMed Central PMCID:
PMC3362194.
Nutritional Management of Phenylketonuria.
Ann Nestle Eng.
2010 Jun;68(2):58-69. doi: 10.1159/000312813. PubMed PMID:
22475869; PubMed Central PMCID:
PMC2901905.
Intravenous or luminal amino acids are insufficient to maintain pancreatic growth and digestive enzyme expression in the absence of intact dietary protein.
Am J Physiol Gastrointest Liver Physiol.
2010 Aug;299(2):G338-47. doi: 10.1152/ajpgi.00165.2010. Epub 2010 Jun 10. PubMed PMID:
20539007; PubMed Central PMCID:
PMC2928533.
Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria.
Mol Genet Metab.
2010 Aug;100(4):303-8. doi: 10.1016/j.ymgme.2010.04.003. Epub 2010 Apr 14. PubMed PMID:
20466571; PubMed Central PMCID:
PMC2906609.
Sustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure.
Am J Physiol Gastrointest Liver Physiol.
2010 Dec;299(6):G1222-30. doi: 10.1152/ajpgi.00367.2010. Epub 2010 Sep 23. PubMed PMID:
20864657; PubMed Central PMCID:
PMC3006245.
Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.
Am J Physiol Endocrinol Metab.
2012 Apr 1;302(7):E885-95. doi: 10.1152/ajpendo.00647.2011. Epub 2012 Jan 31. PubMed PMID:
22297302; PubMed Central PMCID:
PMC3330708.
Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and -5 double knockout mice.
Am J Physiol Gastrointest Liver Physiol.
2012 Apr 15;302(8):G794-804. doi: 10.1152/ajpgi.00372.2011. Epub 2012 Jan 26. PubMed PMID:
22281475; PubMed Central PMCID:
PMC3355561.
Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.
J Acad Nutr Diet.
2012 Aug;112(8):1201-10. doi: 10.1016/j.jand.2012.05.004. Review. PubMed PMID:
22818728; PubMed Central PMCID:
PMC3402906.
Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.
Am J Physiol Gastrointest Liver Physiol.
2012 Sep 1;303(5):G610-22. doi: 10.1152/ajpgi.00184.2012. Epub 2012 Jun 28. PubMed PMID:
22744334; PubMed Central PMCID:
PMC3468558.
Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
PLoS One.
2012;7(9):e45165. doi: 10.1371/journal.pone.0045165. Epub 2012 Sep 18. PubMed PMID:
23028819; PubMed Central PMCID:
PMC3445501.
Effect of exercise on the diurnal variation in energy substrate use during a high-fat diet.
Eur J Appl Physiol.
2012 Nov;112(11):3775-85. doi: 10.1007/s00421-012-2360-6. Epub 2012 Mar 1. PubMed PMID:
22382668; PubMed Central PMCID:
PMC3653165.
Does the PKU diet contribute to impaired renal function?.
J Inherit Metab Dis.
2013 Sep;36(5):903-4. doi: 10.1007/s10545-013-9615-1. Epub 2013 May 8. PubMed PMID:
23653227.
Advances in the nutritional and pharmacological management of phenylketonuria.
Curr Opin Clin Nutr Metab Care.
2014 Jan;17(1):61-8. doi: 10.1097/MCO.0000000000000002. Review. PubMed PMID:
24136088; PubMed Central PMCID:
PMC4004170.
Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.
Mol Genet Metab.
2014 Apr;111(4):452-61. doi: 10.1016/j.ymgme.2014.01.015. Epub 2014 Feb 8. PubMed PMID:
24560888; PubMed Central PMCID:
PMC3995025.
A systematic review of bone mineral density and fractures in phenylketonuria.
J Inherit Metab Dis.
2014 Nov;37(6):875-80. doi: 10.1007/s10545-014-9735-2. Epub 2014 Jul 9. Review. PubMed PMID:
25005329; PubMed Central PMCID:
PMC4208974.
Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.
Am J Physiol Gastrointest Liver Physiol.
2014 Dec 15;307(12):G1147-68. doi: 10.1152/ajpgi.00088.2014. Epub 2014 Oct 23. Review. PubMed PMID:
25342047; PubMed Central PMCID:
PMC4269678.
Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice.
Am J Physiol Gastrointest Liver Physiol.
2015 Oct 1;309(7):G590-601. doi: 10.1152/ajpgi.00211.2015. Epub 2015 Aug 6. PubMed PMID:
26251473; PubMed Central PMCID:
PMC4593820.
What would you like to do?